Skip to main content
Caplight Logo









HKX Capital

HKX Capital

Overview

HKX Capital is a venture capital firm that invests in differentiated healthcare and biotechnology companies at clinical, regulatory, and commercial inflection points.

Year Founded

2026

Portfolio Companies

1

Investments

HKX Capital investments
CompanyDateStageLead
Remedium BioAug 2026Series ACo-investor

Key People

Charlie Regis

General Partner, Venture Partner

Qasim Abbasi

Venture Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is HKX Capital based?

HKX Capital is headquartered in London, United Kingdom.

When was HKX Capital founded?

HKX Capital was founded in 2026.

How many portfolio companies does HKX Capital have?

HKX Capital has 1 portfolio company in Caplight's dataset.

What are some companies in HKX Capital's portfolio?

Portfolio companies visible on Caplight include Remedium Bio.

What was HKX Capital's most recent investment shown here?

HKX Capital's most recent investment in this portfolio sample was in Remedium Bio in 2026.

What sectors does HKX Capital focus on?

HKX Capital focuses on Healthcare & Life Sciences.

What company stages does HKX Capital focus on?

HKX Capital typically invests at the Early stage.

Firmographic Details

HeadquartersLondon
Year Founded2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?